Michael M. Pan

Does significantly elevated lung shunt fraction (LSF >20%) promote extrahepatic progression in patients with hepatocellular carcinoma treated with radioembolization?

R. Salem, A. Gabr, R. Lewandowski, 2021, Nuclear medicine communications.